Green Park & Golf Ventures is a Dallas-based venture capital firm focusing on early-stage medical-related startups. Led by Clay Heighten, M.D., and Carl Soderstrom, the firm leverages over 50 years of operational and financial experience to identify investment opportunities that offer above-market returns. Their typical investment rounds range from seed to Series B.
The firm's portfolio includes notable companies such as Alto, Genomenon, and MicroTransponder. Green Park & Golf Ventures provides strategic solutions, financial backing, and access to a reliable network for its portfolio companies. Their investment philosophy emphasizes delivering value beyond capital, offering expertise and connections in the healthcare and technology sectors.
Green Park & Golf Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments55
Current Portfolio Count38
Total Portfolio Exits1
Top Investment Stages
Series A18 (34.6%)
Seed11 (21.2%)
Series B10 (19.2%)
Series Unknown9 (17.3%)
Series C4 (7.7%)
Stage Mix
Series A 35%Seed 21%Series B 19%Series Unknown 17%Series C 8%
Concentration shown as share of disclosed investments by stage.
Green Park & Golf Ventures - Classification
- Also Known As
- Green Park & Golf Ventures, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end